NVMI Q1 2026 Earnings EPS Beat Drives 472 Stock Surge MLAB Q1 2026 Earnings Strong EPS Beat Highlights Profitability BioXcel Therapeutics BTAI Q1 2026 Earnings EPS Misses Expectations as PreRevenue Biotech Focuses on Pipeline Progress MTX Q1 2026 Earnings EPS Surpasses Estimates by 887 Amid Solid Operational Performance OXLCL Q4 2025 Earnings EPS Falls Short Amid Mixed Market Signals Milestone Pharmaceuticals Q1 2026 Earnings ClinicalStage Biotech Reports Wider Loss Than Expected